Kerala tops most social indices, from health to education, but finds itself battling a drug emergency – 30,000 cases in 2024, ...

Germany holds CanG, US delays, Chile bill; Italy hemp ban; SNDL expands, Tilray cuts outlook, US sales forecast –$21 B.

Spotlight reporters Dugan Arnett and Andrew Ryan discuss their investigation and their new podcast series “Snitch City.” ...

As the last of the anti-CGRP mAbs to enter the migraine market, Vyepti has seen moderate uptake since its FDA approval.

The NIMML Institute, ("NIMML"), a 501 (c)(3) nonprofit institute dedicated to the discovery of novel precision medicines for inflammatory and autoimmune diseases, will present results from two novel ...

Patients with hereditary angioedema who switched from other drugs to donidalorsen for long-term prophylaxis experienced fewer ...

The president, of his own doing, had single-handedly pushed the global economy to the brink of chaos with new tariffs. The ...

Troubled biotech stock Opthea (ASX:OPT), still in the process of crisis talks with investors, has flagged a workforce ...

A MOTHER has revealed that she lost over seven stone after using Ozempic for 12 months. Hannah, who is from the United States ...